TALENs: a widely applicable technology for targeted genome editing
J. Keith Joung,Jeffry D. Sander +1 more
Reads0
Chats0
TLDR
The newly-developed transcription activator-like effector nucleases (TALENs) comprise a nonspecific DNA-cleaving nuclease fused to a DNA-binding domain that can be easily engineered so that TALens can target essentially any sequence.Abstract:
Engineered nucleases enable the targeted alteration of nearly any gene in a wide range of cell types and organisms. The newly-developed transcription activator-like effector nucleases (TALENs) comprise a nonspecific DNA-cleaving nuclease fused to a DNA-binding domain that can be easily engineered so that TALENs can target essentially any sequence. The capability to quickly and efficiently alter genes using TALENs promises to have profound impacts on biological research and to yield potential therapeutic strategies for genetic diseases.read more
Citations
More filters
Journal ArticleDOI
From hacking the human genome to editing organs.
TL;DR: The recent advances regarding human genome edition tools are presented, the numerous implications they have in research and medicine are discussed, and the limits and concerns about such technologies are mentioned.
Correction du gène de la dystrophine avec la méthode CRISPR induced deletion (CinDel)
TL;DR: The next generation of interpreters and interpreters will be able to communicate more easily with each other and will have a better idea of what to expect from each other.
Journal ArticleDOI
Advances in the Development of Gene-Targeting Vectors to Increase the Efficiency of Genetic Modification
Shinta Saito,Noritaka Adachi +1 more
TL;DR: The effect of vector structure on random integration, which is a major obstacle in efficient gene targeting, is described and a novel strategy for negative selection to enhance gene targeting in human cells is discussed.
Journal ArticleDOI
Patient-derived iPSCs, a reliable in vitro model for the investigation of Alzheimer's disease.
Asiamah Ernest Amponsah,Ruiyun Guo,Desheng Kong,Baofeng Feng,Jingjing He,Wei Zhang,Xin Liu,Xiaofeng Du,Zhenhuan Ma,Boxin Liu,Jun Ma,Jun Ma,Huixian Cui,Huixian Cui +13 more
TL;DR: In this article, an overview of Alzheimer's disease and induced pluripotent stem cells (iPSCs) in their optimized form in AD mechanistic studies and preclinical drug testing is provided.
Journal ArticleDOI
The advances and challenges of Gene Therapy for Duchenne Muscular Dystrophy
TL;DR: The new CRISPR-Cas9 system is included, which permits not only major progress in the development of new treatments based on genome editing but also the production of new animal models.
References
More filters
Journal ArticleDOI
Breaking the Code of DNA Binding Specificity of TAL-Type III Effectors
Jens Boch,Heidi Scholze,Sebastian Schornack,Angelika Landgraf,Simone Hahn,Sabine Kay,Thomas Lahaye,Anja Nickstadt,Ulla Bonas +8 more
TL;DR: The functionality of a distinct type of DNA binding domain is described and allows the design ofDNA binding domains for biotechnology.
Journal ArticleDOI
Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting
Tomas Cermak,Erin L. Doyle,Michelle Christian,Li-Li Wang,Yong Zhang,Clarice Schmidt,Joshua A. Baller,Nikunj V. Somia,Adam J. Bogdanove,Daniel F. Voytas +9 more
TL;DR: A method and reagents for efficiently assembling TALEN constructs with custom repeat arrays are presented and design guidelines based on naturally occurring TAL effectors and their binding sites are described.
Journal ArticleDOI
A TALE nuclease architecture for efficient genome editing
Jeffrey C. Miller,Siyuan Tan,Guijuan Qiao,Kyle A. Barlow,Jianbin Wang,Danny F Xia,Xiangdong Meng,David Paschon,Elo Leung,Sarah J. Hinkley,Gladys P Dulay,Kevin Hua,Irina Ankoudinova,Gregory J. Cost,Fyodor D. Urnov,H. Steve Zhang,Michael C. Holmes,Lei Zhang,Philip D. Gregory,Edward J. Rebar +19 more
TL;DR: This study identifies TALE truncation variants that efficiently cleave DNA when linked to the catalytic domain of FokI and uses them to generate discrete edits or small deletions within endogenous human NTF3 and CCR5 genes at efficiencies of up to 25%.
Journal ArticleDOI
Genome editing with engineered zinc finger nucleases
TL;DR: A broad range of outcomes has resulted from the application of the same core technology: targeted genome cleavage by engineered, sequence-specific zinc finger nucleases followed by gene modification during subsequent repair.
Journal ArticleDOI
A Simple Cipher Governs DNA Recognition by TAL Effectors
TL;DR: It is shown that a repeat-variable pair of residues specifies the nucleotides in the target site, one pair to one nucleotide, with no apparent context dependence, which represents a previously unknown mechanism for protein-DNA recognition that explains TAL effector specificity, enables target site prediction, and opens prospects for use of TAL effects in research and biotechnology.
Related Papers (5)
ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering
DNA targeting specificity of RNA-guided Cas9 nucleases
Patrick D. Hsu,David A. Scott,David A. Scott,Joshua A. Weinstein,Joshua A. Weinstein,F. Ann Ran,F. Ann Ran,F. Ann Ran,Silvana Konermann,Silvana Konermann,Vineeta Agarwala,Vineeta Agarwala,Vineeta Agarwala,Yinqing Li,Yinqing Li,Eli J. Fine,Xuebing Wu,Ophir Shalem,Ophir Shalem,Thomas J. Cradick,Luciano A. Marraffini,Gang Bao,Feng Zhang,Feng Zhang +23 more